Effect of programmed exercise on insulin sensitivity in postmenopausal women
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Bueno-Notivol, JuanCalvo-Latorre, Julia
Alonso-Ventura, Vanesa
Pasupuleti, Vinay
Hernandez, Adrian V.
Pérez-López, Faustino R.
Issue Date
2017-06
Metadata
Show full item recordCitation
Effect of programmed exercise on insulin sensitivity in postmenopausal women 2017:1 MenopausePublisher
Lippincott Williams and WilkinsJournal
MenopauseDOI
10.1097/GME.0000000000000936Additional Links
http://Insights.ovid.com/crossref?an=00042192-900000000-97743Abstract
OBJECTIVE:: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing the effect of programmed exercise for at least 12 weeks, in postmenopausal women on insulin sensitivity-related outcomes (ISROs), including fasting insulin, C-peptide, insulin growth factor (IGF-1) and IGF-binding protein (IGFBP-3), Homeostatic Model Assessment-Insulin Resistance (HOMA-IR), and anthropometric variables. METHODS:: Searches were conducted in PubMed-Medline, Embase, Scopus, Web of Science, and Cochrane Library from inception through May 3, 2016, for studies published in all languages. Extracted data included characteristics of the study design, study participants, intervention, and outcome measures. Types of exercise were classified into “mid-term exercise intervention” (MTEI, 3-4 months exercise duration) and a “long-term exercise intervention” (LTEI, 6-12 months exercise duration). Risk of bias in RCTs was evaluated with the Cochrane tool. We used random-effects models for meta-analyses. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RESULTS:: Seven RCTS (n?=?580) evaluating the effects of programmed exercise on ISROs were included. In three RCTs, MTEI significantly lowered insulin levels (mean difference [MD] −6.50?pmol/L, 95% confidence interval [CI] −11.19, −1.82, P?=?0.006) and HOMA-IR values (MD −0.18, 95% CI −0.34, −0.03, P?=?0.02) when compared with controls. LTEI had no significant effect on insulin levels (P?=?0.19) or HOMA-IR values (P?=?0.68) in four and three RCTs, respectively. There were no significant differences between exercise intervention versus controls in circulating IGF-1, glucose, triglycerides with both MTEI and LTEI, and in IGFBP-3 with LTEI. There were significant reductions in body mass index (BMI, kg/m) (MD −1.48, 95% CI −2.48, −0.48, P?=?0.004) and in body fat percentage (MD −2.99, 95% CI −4.85, −1.14, P?=?0.01) after MTEI; and in waist circumference after both MTEI (MD −1.87, 95% CI −3.02, −0.72, P?=?0.001) and LTEI (MD −3.74, 95% CI −6.68, −0.79). Heterogeneity of effects among studies was moderate to low. CONCLUSION:: Exercising for 3 to 4 months significantly lowered insulin levels and HOMA-IR values, BMI waist circumference, and percentage body fat mass; exercising for 6 to 12 months lowered waist circumference in postmenopausal women.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/restrictedAccessLanguage
engDescription
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.ISSN
1072-3714ae974a485f413a2113503eed53cd6c53
10.1097/GME.0000000000000936
Scopus Count
Collections